Retrospective Study
Copyright ©The Author(s) 2023.
World J Transplant. Mar 18, 2023; 13(3): 96-106
Published online Mar 18, 2023. doi: 10.5500/wjt.v13.i3.96
Table 2 Post-transplant outcomes
Outcome
ALF among n = 37, n (%)
ESCLD among n = 195, n (%)
P value
Vascular complications
AV malformation post-liver biopsy0 (0)1 (0.5)1.000
Retroperitoneal hematoma, femoral vein bypass cannula0 (0)1 (0.5)1.000
HAS2 (5.4)13 (6.7)1.000
PVS0 (0)14 (7.2)0.134
HAT1 (2.7)10 (5.1)1.000
PVT1 (2.7)7 (3.6)1.000
HVS1 (2.7)0 (0)0.159
Biliary complications
CHD sludge0 (0)2 (1)1.000
Biliary stricture3 (8.1)21 (10.8)0.775
Bile leak0 (0)23 (11.8)0.031
Cause of graft lossn = 5n = 27
HAT0 (0)9 (33.3)0.288
PNF2 (40)5 (18.5)0.296
Chronic rejection3 (60)6 (22.2)0.121
Biliary tract complications0 (0)7 (25.9)0.560
Cause of deathn = 9n = 17
Unknown0 (0)5 (29.4)0.129
Cardiopulmonary3 (33.3)1 (5.9)0.104
Cerebral oedema1 (11.1)0 (0)0.346
Fungal infection1 (11.1)0 (0)0.346
Gastrointestinal0 (0)1 (5.9)1.000
Intracranial hemorrhage1 (11.1)0 (0)0.346
Liver failure1 (11.1)4 (23.5)0.628
Recurrence of disease0 (0)1 (5.9)1.000
Sepsis2 (22.2)5 (29.4)1.000